Stay updated on Tepotinib Phase II Clinical Trial

Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib Phase II Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New cross-registry identifiers from China and Japan registries were added (CTR20192576, jRCT2080223315, Japic CTI-163370) and the study revision updated to v3.6.4. Older identifiers and the previous revision (v3.6.3) were removed.
    Difference
    0.2%
    Check dated 2026-07-21T12:53:27.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.6.0 to v3.6.3 on the page. This indicates a version update, likely affecting underlying structure or metadata rather than visible content.
    Difference
    0.0%
    Check dated 2026-06-30T03:24:30.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now shows recruitment is no longer open to participants. New guidance sections—How to Read a Study Record, Common Questions, and How to Join a Study—have been added to help users navigate and understand the record.
    Difference
    0.2%
    Check dated 2026-06-16T00:15:59.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a small build update without altering the study content.
    Difference
    0.0%
    Check dated 2026-06-09T01:55:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.3 to v3.5.4, indicating a minor site update. No changes to the study details or page structure are evident.
    Difference
    0.0%
    Check dated 2026-05-18T19:34:03.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page’s displayed software/content “Revision” label has been updated from v3.5.2 to v3.5.3, indicating a release/version change without altering the underlying study information.
    Difference
    0.0%
    Check dated 2026-04-27T09:31:31.000Z thumbnail image

Stay in the know with updates to Tepotinib Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.